Introduction
Gene transfer, whether for therapeutic or experimental purposes, is often inefficient. Recombinant adenoviruses are among the most widely used vectors, but many cell types require very high viral doses to achieve sufficient transduction. This raises costs and, when used in vivo, increases the chances of adverse immune responses of the type that have already led to the death of at least one subject in a clinical trial. 1 Nevertheless, adenoviruses offer considerable advantages as gene transfer vectors, including broad host range, ease of manufacture and the ability to infect quiescent cells. 2 The challenge is to make them more efficient.
Several approaches have already been explored in this regard. These include using novel serotypes of adenovirus from human and nonhuman sources, 3, 4 engineering viral capsid proteins to increase tissue specificity or enhance binding to cell surfaces [5] [6] [7] [8] and reducing the immunogenicity of transduced cells by the elimination of viral coding sequences. 9 Although several of these strategies considerably increase transduction efficiency, they are complex, expensive procedures that have to be repeated for each new application. Exploring a different approach, we note that electrostatic repulsion between negative charges on the surfaces of cells and adenoviruses presents a considerable barrier to their mutual engagement. Previous investigators have used polycations 10, 11 and Ca 2+ 12,13 to overcome this problem. However, increases in transduction efficiency by these means have been modest.
Because of their very high charge:volume ratios, trivalent lanthanide and yttrium cations (Ln 3+ ) neutralize anionic moieties very efficiently and serve as bridges between negatively charged functional groups. 14 As additional advantages, lanthanides are safe and inexpensive. In this study, we investigated the use of Ln 3+ to improve the transduction efficiency of first generation adenovirus vectors by forming Ln 3+ -adenovirus complexes prior to infection. The data demonstrate a dramatic improvement in transduction, confirmed for established and primary mesenchymal cell lines from several different mammalian species in vitro and two different tissues in vivo. This suggests a broad utility for this technology in a wide range of gene transfer applications.
Results

Effect of Ln
3+ on adenoviral transduction of C3H10T (Figure 1a) . Using a high dose of 50 000 v.p. per cell, all Ln 3+ -enhanced transgene expression at concentrations of 0.2 mM or lower, but the effects were more modest, ranging from a 5-to 10-fold increase. Since La 3+ provided the greatest enhancement of transgene expression at both viral doses, this Ln 3+ was selected for further characterization.
A wide-ranging dose-response experiment was performed to examine more comprehensively the influence of viral titer and La 3+ concentration (Figure 1b ). For each viral dose, a 10-1000-fold increase in transgene expression was observed at La 3+ concentrations of 0.05 and 0.2 mM. However, the effect diminished with concentrations of 0.5 mM La 3+ and above ( Figure 1b and data not shown). Although La 3+ increased transduction efficiency at all viral doses, the magnitude of the effect was greatest at low viral doses and decreased considerably as the dose increased. The addition of La 3+ to cells previously transduced with Ad.Luc did not enhance luciferase activity (data not shown), suggesting that it acts primarily by facilitating viral transduction rather than through the regulation of transgene expression.
To determine the effects of other physical variables on La-mediated gene transfer, we examined phosphate concentration and pH (Figures 1c and d) . Phosphate was tested because the addition of Ln 3+ to DMEM-virus preparations produced a fine precipitate; DMEM contains 0.91 mM PO 4 3À and Ln 3+ readily form insoluble phosphates.
14 The stimulation of transduction had an absolute requirement for phosphate with an increase of approximately four log orders occurring at the concentration of phosphate found in DMEM (Figure 1c ). Indeed, it was possible to gain large increases in transduction efficiency by simply adding La 3+ to suspensions of virus in saline solution containing 1 mM Na 2 HPO 4 (data not shown). It was not possible to form LaPO 4 -adenovirus co-precipitates in the presence of 5% fetal bovine serum, but serum did not alter the transducing power of preformed precipitates (data not shown). Transduction efficiency in the presence of 0.2 mM La 3+ increased with increasing pH, reaching a maximum at pH 8.5. This was consistent with the pH of unbuffered DMEM (pH 8-8.5) used for complex formation in the initial screening experiments (Figure 1d ).
Since calcium phosphate co-precipitates have been used to enhance adenovirus transduction efficiency, 12 we compared the effects of Ca 2+ and La 3+ on transduction of C3H10T 1 2 cells. At a dose of 100 v.p. per cell, the inclusion of Ca 2+ had only a minor effect on transduction, whereas La 3+ -enhanced luciferase expression by several log orders (Figure 1e ). At 50 000 v.p. per cell, the greatest increment in luciferase expression was reduced to 
Improved physiological responses in primary cells using La 3+ -enhanced transduction
Interleukin-1 (IL-1) is a key mediator of many inflamma tory and degenerative diseases. 16 Its natural antagonist, the IL-1 receptor antagonist (IL-1Ra), has therapeutic potential in such diseases, but efficacy requires a high molar excess over IL-1. 17 It is thus a good candidate for La-enhanced gene delivery. This possibility was examined in detail using two different, clinically relevant target cells in primary culture.
Primary cultures of rat synovial fibroblasts and bovine MSCs were transduced with adenovirus carrying human IL-1Ra cDNA (Ad.IL-1Ra) at high and low viral doses in the presence or absence of La 3+ and compared to C3H10T 3+ led to a marked enhancement of IL-1Ra production in all cell types, especially at low viral doses. Similar results were obtained using primary cultures of bovine articular chondrocytes and human, bone marrow-derived MSCs, as well as an established line of murine bone marrow stromal cells, osteogenesis imperfecta mouse (OIM) 18 (data not shown).
To confirm potential physiological utility, we employed an in vitro system in which primary cultures of rat synovial fibroblasts were transduced with a range of viral doses between 200 and 18 000 v.p. per cell of Ad.IL1Ra or Ad.Luc in the presence or absence of La 3+ and challenged with IL-1b (5 ng ml À1 ) to induce the synthesis of nitric oxide (NO) (Figure 4a ). In the absence of La 3+ , synoviocytes synthesized modest amounts of IL-1Ra that were not able to block IL-1 induced synthesis of NO (Figures 4b and c left graph) . In sharp contrast, those cultures transduced in the presence of La 3+ synthesized strikingly higher amounts of IL-1Ra which, at the highest two viral doses, almost completely inhibited IL-1-mediated induction of NO as compared to Ad.Luc controls (Figures 4b and c right graphs) . This protective effect corresponded to secreted levels of IL-1Ra La-enhanced adenoviral transduction GD Palmer et al transgene product of 4150 ng ml À1 in the conditioned media which is consistent with the inhibitory effects of transgenic IL-1Ra reported by Gouze et al. 19 Thus, by the simple inclusion of La 3+ in the transduction protocol, it is possible to obtain functional levels of transgene expression from an otherwise ineffective dose of virus.
Effect of La
3+ on adenovirus-mediated gene transfer in vivo
To evaluate the efficacy of La 3+ in vivo, vectors were injected either intra-articularly or intra-muscularly into Wistar rats. To target synovium, 10 9 v.p. of Ad.IL-1Ra were injected into the knee joints. This is a 10-fold lower dose than previously administered to achieve an antiarthritic effect in rat models of arthritis. 20 After 72 h, the rats were euthanized, and the joints were examined for the production of human IL-1Ra. Addition of La 3+ to Ad.IL-1Ra markedly increased production of human IL1Ra as compared to vector alone (Figure 5a ). This is consistent with the findings of a parallel experiment in which the same dose of Ad.GFP was injected into knee joints, resulting in considerably greater numbers of GFP positive cells in the synovia of knees receiving virus with La 3+ (Figure 5b ). La 3+ also enhanced the in vivo transduction by Ad.IL-1Ra following injection of gastrocnemius calf muscle (Figure 5c ). Compared to intra-articular levels, intra-muscular expression of human IL-1Ra was approximately fivefold lower; however, the La 3+ effect was of approximately the same magnitude. These findings suggest that La-enhanced gene delivery is applicable to multiple tissue types and may be used to overcome the tropic constraints of adenoviral vectors.
Discussion
The simple addition of La 3+ , under mild conditions, increases dramatically the transduction efficiency of adenovirus vectors. This was demonstrated for an established mesenchymal cell line, C3H10T 1 2 , and primary cell cultures isolated from several different mammalian species in vitro, as well as rat tissues in vivo following intra-articular and intra-muscular injection. 
La-enhanced adenoviral transduction
GD Palmer et al La 3+ was examined on the basis of its ability to neutralize and bridge negative charges on the surfaces of cells and viruses.
14 However, the actual mode of action appears to be more complicated. Because of the lanthanide contraction, the charge:volume ratios of Ln 3+ at equivalent coordination numbers increase in the order La
14 As shown in Figure 1a , this ranking does not reflect the abilities of the individual ions to increase transduction; in fact, the most effective ion, La 3+ , has the smallest charge:volume ratio. An alternative explanation is provided by data suggesting that the formation of a fine LaPO 4 -virus co-precipitate is important, a conclusion reinforced by our ability to generate preparations of enhanced potency in saline solution containing 1 mM sodium phosphate. This, however, does not explain why precipitates formed with LaPO 4 are more effective than those formed with Ca 3 (PO 4 ) 2 or, indeed, why there are differences between different lanthanides. The unequal potencies may reflect important differences in the abilities of calcium and lanthanide phosphates to precipitate virus, or differences in particle sizes or surface chemistries of the precipitates. La 3+ increases both the percentage of transduced cells and the level of transgene expression per cell. Because it does not enhance transgene expression by cells previously transduced, it appears to work by increasing the uptake of viral genomes. A possible mechanism for La 3+ -enhanced gene transfer involves circumventing the coxsackie virus and adenovirus receptor (CAR) that adenovirus typically uses for cell entry. Expression of CAR is reportedly low in MSC populations. 21 Consistent with these reports, we observed only modest levels of transduction in both C3H10T 1 2 and primary MSCs using free vector. Moreover, the magnitude of the La 3+ effect diminished with increasing viral doses where non-CARmediated pathways of viral entry are likely to be operative.
Previous investigators have added Ca 2+ or polycations to improve adenoviral transduction. As shown here, La 3+ is superior to Ca 2+ , especially at low viral titers. According to the literature, polycations generally improve transduction efficiencies by 10-50-fold, 10, 11 whereas La 3+ can provide increases of several orders of magnitude. The recent data of Bosch et al. 22 are informative in this regard, because they record the effect of a popular, new, commercial polyamine (GeneJammer, Stratagene, La Jolla, CA, USA) 10 on the adenoviral transduction of MSCs, the type of cell used in the present studies.
Bosch et al. record a 5.5-fold increase in transduction efficiency using this polyamine, considerably less than achieved here with La 3+ . Because the effects of La 3+ are particularly striking at low viral doses, the technology should permit important biological responses to gene transfer using only small amounts of vector. This will greatly reduce cost, while enhancing utility and safety. The enhanced transducing ability of LaPO 4 -adenovirus precipitates is not inhibited by serum and, as we have shown, these formulations are effective for in vivo gene delivery. Thus, the use of La 3+ may permit the successful application of first generation adenovirus vectors in vivo at titers that do not provoke strong innate immune reactions. In this regard, the extremely low toxicity of La 3+ favors its use in vivo, and it is therefore particularly encouraging that its stimulatory effects are also seen in this setting.
The clinical application of lanthanides is also supported by their extremely low toxicities (reviewed in Evans 14 ). Indeed, Gd-complexes are already used as contrast enhancing agents in magnetic resonance imaging and lanthanum carbonate is used to treat hyperphosphatemia in dialysis patients. In general, it has been difficult to establish any toxicity in experimental animals for orally administered lanthanides. Intraperitoneal or intravenous injection typically produces LD 50 values of 50-500 and 3-100 mg kg À1 , respectively.
14 Because lanthanum phosphate is extremely insoluble, its in vivo application as a co-precipitate with adenovirus is likely to produce very little toxicity. This opens the way for the expanded in vivo use of adenovirus vectors as experimental tools and as instruments of gene therapies.
Methods
Vectors
First generation (DE1, DE3) serotype 5 adenovirus vectors carrying Ad.Luc, Ad.GFP or human interleukin-1 receptor antagonist (Ad.IL-1Ra) were constructed by the method of Hardy et al. 23 as described in detail by Palmer et al. 24 In each case, the CMV immediate early promoter was used to drive transgene expression. Recombinant viruses were amplified in 293 cells and purified over three successive CsCl gradients. Following dialysis in 10 mM Tris-HCl, pH 7.8, 150 mM NaCl, 10 MgCl 2 and 4% sucrose, the preparations were aliquotted and stored at À801. Viral titers were estimated by optical density and standard plaque assay. Preparations of 10 12 -10 13 v.p. per ml were obtained. The ratio of v.p. to plaque forming units (PFU) on 293 cells was approximately 100:1.
Cell culture
The murine mesenchymal cell line C3HT10 La-enhanced adenoviral transduction GD Palmer et al were established by sequential pronase and collagenase digestion of the membrane, as previously described. 26 MSCs were isolated from the trabecular bone of femurs from 6-to 12-week-old bovine calves (Research 87 Inc., Marlborough, MA, USA) using a protocol based upon that of Tuli et al. 27 Briefly, trabecular bone fragments were harvested with a curet, suspended in DMEM and subjected to repeated rounds of vortexing. After repeated passage through a 20-gauge needle, cells were plated into DMEM supplemented with 10% fetal bovine serum and antibiotics. Human and rabbit MSCs were obtained from bone marrow. Marrow was layered onto FicollPaque PLUS (Stem Cell Technologies) density gradient, centrifuged (400 g, 30 min) and the interface cells recovered. Cells were seeded into DMEM supplemented with 10% fetal bovine serum and antibiotics. Nonadherent cells were removed by washing and medium change and the adherent, fibroblastic cells retained for further culture. Bovine articular cartilage was harvested from the stifle joints of 6-12-week-old calves, and the chondrocytes released by sequential digestion in pronase and collagenase. Cell suspensions were filtered through a 70 mm nylon filter (Nunc) and plated into 25 cm 2 tissue culture flasks in DMEM containing 10% fetal bovine serum and antibiotics. All cell cultures were infected with adenovirus vectors 24-48 h after seeding, at which point cultures were 70% confluent.
Formation of lanthanide-virus preparations
Lanthanides and yttrium, obtained as their anhydrous chloride salts from Sigma-Aldrich (St Louis, MO, USA), were dissolved in deionized water adjusted to pH 5.5-6.0 and maintained as 0.4 M stock solutions in tightly capped storage tubes at 4 1C. Fresh stock solutions were made every 2 weeks.
Various doses of adenoviral vector stocks were added to serum-free DMEM to generate the final titers indicated in the text. The final concentrations of LnCl 3 were achieved by the addition of the appropriate volumes of a 0.4 M stock solution. The mixtures were gently vortexed and incubated at room temperature for 30 min prior to infection. Control groups lacking Ln 3+ were generated in parallel. To determine the effect of phosphate ions, complexes were generated using phosphate-free DMEM and exogenous Na 2 HPO 4 added to achieve the desired phosphate concentration. In certain experiments, complexes were generated in saline (0.9% w/v) solution containing 1 mM Na 2 HPO 4. To adjust the pH, serum-free DMEM was buffered by the addition of HEPES or Tris-HCl immediately before complex formation. These buffers were selected because they do not interact strongly with Ln 3+ . 14 After complex formation, 200 ml volumes of viruslanthanide suspension, or control virus, were added to cells in 24-well plates, and 300 ml serum-free DMEM was added. After incubation at 371 for 2-4 h, the wells were aspirated, and fresh DMEM, supplemented with serum and antibiotics was added.
Measurement of transgene expression
For measurement of luciferase, cultures were harvested 72 h post-infection into lysis buffer (Promega, Madison, WI, USA) and incubated at room temperature for 15 min. Samples were analyzed by mixing with an equal volume of Bright-Glo luciferase assay substrate (Promega) and measuring emitted light with an Autolumat Plus luminometer. Total protein concentrations of the lysates were determined with the Bradford's reagent (SigmaAldrich) according to the manufacturer's instructions.
For analysis of GFP expression, cells were recovered by trypsin digestion, pelleted and resuspended to a concentration of 5 Â 10 5 cells per ml in phosphatebuffered saline. Analyses were performed with a Cytomics FC 500 (Beckman Coulter, Fullerton, CA, USA) flow cytometer. Fluorescence emission was measured with a bandpass filter at 525 nm, collecting representative fluorescent data from 10 000 cells per sample.
IL-1Ra was measured in conditioned media using the Quantikine human IL-1Ra immunoassay kit (R&D Systems, Minneapolis, MN, USA), which does not recognize rat or bovine IL-1Ra.
Nitric oxide measurement
NO production was measured as the accumulation of NO 2 À in conditioned media using the Griess reaction, with sodium nitrite as a standard. 28 Nitrate in the media was first converted to nitrite by the action of nitrite reductase. Briefly, one volume of culture medium was mixed with one volume of Griess reagent (sulfanilamide 1% w/v in 2.5% H 3 PO 4 , and N-naphthylethylenediamine dihydrochloride 0.1% w/v in H 2 O) for 5 min in 96-well plates. The absorbance at 550 nm was then measured on a MR5000 microplate reader.
In vivo gene delivery and transgene expression
Young adult male Wistar rats (Charles River Laboratories, Wilmington, MA, USA) were used; all experiments were approved by the Harvard Medical Standing Committee on Animals. Knee joints or calf, gastrocnemius, muscles were injected with 10 9 v.p. adenovirus, prepared in the presence or absence of La 3+ , in a final volume of 50 ml serum-free DMEM. After 72 h, animals were euthanized by CO 2 asphyxiation.
To measure human IL-1Ra production, injected knee joints and whole calf muscles were harvested and placed overnight in tissue culture medium. Knee joints were dissected to expose the articular surfaces and facilitate secretion of transgene product into the culture medium. Muscle was dissected into fragments of approximately 5 mm. After dissection, tissues were placed into 24-well plates containing 1 ml supplemented DMEM and incubated for 24 h. Conditioned media were recovered and stored at À20 1C until assay of IL-1Ra by enzyme-linked immunosorbent assay. For knees receiving Ad.GFP, the synovial linings were carefully dissected from the joint capsule and examined visually using a Leica DMIL inverted fluorescence microscope.
Statistical analysis
Statistical analyses were performed using Student's t-test, with Po0.05. indicating statistical significance.
